Harmony Biosciences Holdings (HRMY) Interest Expenses (2023 - 2026)
Harmony Biosciences Holdings' Interest Expenses was $3.07 million in Q2 2026, down 15.8% from $3.65 million a year earlier and down 5.1% from the prior quarter.
Harmony Biosciences Holdings (HRMY) Interest Expenses (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harmony Biosciences Holdings' Interest Expenses was $13.47 million through Jun 30, 2026, down 16.0% year-over-year; for FY2025, it came in at $14.65 million, down 16.3% from FY2024.
- Interest Expenses shows a four-year compound annual growth rate of -11.8% (FY2021 to FY2025).
- In earlier years, Interest Expenses was $17.5 million in FY2024 (-26.4%), $23.76 million in FY2023 (+26.4%), $18.8 million in FY2022 (-22.3%) and $24.19 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Interest Expenses in data going back to Q1 2023.
- Compared with a year earlier, Interest Expenses has declined for ten straight quarters, with an average decline of 18.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Interest Expenses ranged from 12.2% (Q4 2024) to 38.0% (Q3 2024).
- Per Business Quant data, HRMY's Interest Expenses in the three quarters before Q2 2026 was $3.23 million (Q1 2026), $3.55 million (Q4 2025) and $3.62 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 3.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | 3.62 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 4.21 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 4.54 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 7.01 Mn |
| Jun 30, 2023 | 6.22 Mn |
| Mar 31, 2023 | 5.73 Mn |
Harmony Biosciences Holdings Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=HRMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();